首页|期刊导航|癌症生物学与医学(英文版)|Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer

Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancerOA

Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer

Liming Liu;Hui Guo;Zhiyong Wang;Yanfen Cui;Fei Zhang;Ruifang Niu;Yichu Zhang;Xiaoxue Li;Yueni Mo;Lanlan Song;Yidi Jia;Luoming Zhang;Wei Zhou;He Zhang

Public Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,ChinaPublic Laboratory,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin 300060,China||Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China||Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,China

Breast cancerintratumor heterogeneityexosomesEPHA2TGF-βRI

Breast cancerintratumor heterogeneityexosomesEPHA2TGF-βRI

《癌症生物学与医学(英文版)》 2026 (8)

1128-1155,中插1-中插6,34

This work was supported by grants from the National Natural Science Foundation of China(Grant Nos.82573172,82472996,82073085,and 82203687).

10.20892/j.issn.2095-3941.2025.0440

评论